Substituted bicyclolactam compounds

Details for Australian Patent Application No. 2008281545 (hide)

Owner Pfizer Products Inc.

Inventors Dow, Robert Lee; Munchhof, Michael John

Agent Spruson & Ferguson

Pub. Number AU-B-2008281545

PCT Pub. Number WO2009/016462

Priority 60/953,507 02.08.07 US

Filing date 22 July 2008

Wipo publication date 5 February 2009

Acceptance publication date 8 December 2011

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

11 February 2010 PCT application entered the National Phase

  PCT publication WO2009/016462 Priority application(s): WO2009/016462

8 December 2011 Application Accepted

  Published as AU-B-2008281545

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008281551-Identification and authentication of devices in a network

2008281543-Pyrazole compounds and their use as Raf inhibitors